Cardiovascular therapy in the newborn
Sandor, G.G.
Clinical and Investigative Medicine. Medecine Clinique et Experimentale 8(4): 360-367
1985
ISSN/ISBN: 0147-958X PMID: 3907921 Document Number: 267314
Considerations for the use of the principal inotropic agents (digoxin and dopamine) in the newborn are discussed. The role of Prostaglandin-E in retaining the patency of the ductus arteriosus in the initial treatment of anomalous vessel formation is outlined. Conversely, chemotherapeutic possibilities for inhibiting prostaglandin production and thus encouraging closure of the ducts prior to surgical intervention are described.